SARS-CoV-2 reinfection in a cohort of 43,000 antibody-positive individuals followed for up to 35 weeks
View ORCID ProfileLaith J. Abu-Raddad, View ORCID ProfileHiam Chemaitelly, View ORCID ProfilePeter Coyle, View ORCID ProfileJoel A. Malek, Ayeda A. Ahmed, Yasmin A. Mohamoud, Shameem Younuskunju, View ORCID ProfileHoussein H. Ayoub, View ORCID ProfileZaina Al Kanaani, View ORCID ProfileEinas Al Kuwari, View ORCID ProfileAdeel A. Butt, View ORCID ProfileAndrew Jeremijenko, View ORCID ProfileAnvar Hassan Kaleeckal, Ali Nizar Latif, View ORCID ProfileRiyazuddin Mohammad Shaik, View ORCID ProfileHanan F. Abdul Rahim, View ORCID ProfileGheyath K. Nasrallah, View ORCID ProfileHadi M. Yassine, View ORCID ProfileMohamed G. Al Kuwari, View ORCID ProfileHamad Eid Al Romaihi, View ORCID ProfileMohamed H. Al-Thani, Abdullatif Al Khal, View ORCID ProfileRoberto Bertollini
doi: https://doi.org/10.1101/2021.01.15.21249731
Laith J. Abu-Raddad
1Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
2World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
3Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA
Hiam Chemaitelly
1Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
2World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
Peter Coyle
4Hamad Medical Corporation, Doha, Qatar
Joel A. Malek
5Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
6Department of Genetic Medicine, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
Ayeda A. Ahmed
5Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
Yasmin A. Mohamoud
5Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
Shameem Younuskunju
5Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
Houssein H. Ayoub
7Department of Mathematics, Statistics, and Physics, Qatar University, Doha, Qatar
Zaina Al Kanaani
4Hamad Medical Corporation, Doha, Qatar
Einas Al Kuwari
4Hamad Medical Corporation, Doha, Qatar
Adeel A. Butt
3Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA
4Hamad Medical Corporation, Doha, Qatar
Andrew Jeremijenko
4Hamad Medical Corporation, Doha, Qatar
Anvar Hassan Kaleeckal
4Hamad Medical Corporation, Doha, Qatar
Ali Nizar Latif
4Hamad Medical Corporation, Doha, Qatar
Riyazuddin Mohammad Shaik
4Hamad Medical Corporation, Doha, Qatar
Hanan F. Abdul Rahim
8College of Health Sciences, QU Health, Qatar University, Doha, Qatar
Gheyath K. Nasrallah
9Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar
10Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
Hadi M. Yassine
9Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar
10Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
Mohamed G. Al Kuwari
11Primary Health Care Corporation, Doha, Qatar
Hamad Eid Al Romaihi
12Ministry of Public Health, Doha, Qatar
Mohamed H. Al-Thani
12Ministry of Public Health, Doha, Qatar
Abdullatif Al Khal
4Hamad Medical Corporation, Doha, Qatar
Roberto Bertollini
12Ministry of Public Health, Doha, Qatar
Data Availability
All data are available within the manuscript and supplementary materials.
Posted January 15, 2021.
SARS-CoV-2 reinfection in a cohort of 43,000 antibody-positive individuals followed for up to 35 weeks
Laith J. Abu-Raddad, Hiam Chemaitelly, Peter Coyle, Joel A. Malek, Ayeda A. Ahmed, Yasmin A. Mohamoud, Shameem Younuskunju, Houssein H. Ayoub, Zaina Al Kanaani, Einas Al Kuwari, Adeel A. Butt, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul Rahim, Gheyath K. Nasrallah, Hadi M. Yassine, Mohamed G. Al Kuwari, Hamad Eid Al Romaihi, Mohamed H. Al-Thani, Abdullatif Al Khal, Roberto Bertollini
medRxiv 2021.01.15.21249731; doi: https://doi.org/10.1101/2021.01.15.21249731
SARS-CoV-2 reinfection in a cohort of 43,000 antibody-positive individuals followed for up to 35 weeks
Laith J. Abu-Raddad, Hiam Chemaitelly, Peter Coyle, Joel A. Malek, Ayeda A. Ahmed, Yasmin A. Mohamoud, Shameem Younuskunju, Houssein H. Ayoub, Zaina Al Kanaani, Einas Al Kuwari, Adeel A. Butt, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul Rahim, Gheyath K. Nasrallah, Hadi M. Yassine, Mohamed G. Al Kuwari, Hamad Eid Al Romaihi, Mohamed H. Al-Thani, Abdullatif Al Khal, Roberto Bertollini
medRxiv 2021.01.15.21249731; doi: https://doi.org/10.1101/2021.01.15.21249731
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2936)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12741)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4581)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (388)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4348)
- Nursing (236)
- Nutrition (638)
- Oncology (2268)
- Ophthalmology (645)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6934)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (487)
- Toxicology (60)
- Transplantation (210)
- Urology (180)